OpioidRedoxStudyII

Sponsor
EPC Education s.r.o.
Study ID
NCT07338084
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This observational study aims to examine the relationship between opioid use and redox balance in adults. Redox balance reflects the level of oxidative stress in the body, which is known to play an important role in many biological processes and diseases. Participants who use opioids will be included in the study. No experimental treatment or changes to current medical care will be provided as part of this study. Biological samples may be collected to assess redox-related biomarkers, and relevant clinical and demographic information will be recorded. The results of this study are expected to improve understanding of how opioid exposure is associated with redox balance in adults. This information may help inform future research on the biological effects of opioids and potential strategies to reduce harm associated with long-term opioid use.

Key Dates

First listed
Jan 13, 2026
Start date
Jun 30, 2026
Status verified
Jan 2026
Primary completion
Dec 30, 2026
Completion
Dec 31, 2029

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Group 1
    Tramadol Cohort
  • Arm: Group 2
    Tapentadol Cohort
  • Arm: Group 3
    Buprenorphine - Morphin Cohort
  • Arm: Group 4
    Fentanyl Cohort

Primary Outcome Measure

Redox Balance Assessed by Circulating Redox-Related Biomarkers [ Time Frame: At baseline (at enrollment) ]

Central Contacts

Find similar trials

Nationwide
Substance use disorder trialsBehavioral health trialsAddiction medicine trials

Related Studies